Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 499-501, 2003; 10.1373/49.3.499
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rashed, M. S.
Right arrow Articles by Legaspi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rashed, M. S.
Right arrow Articles by Legaspi, S.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:499-501.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Rapid Determination of Orotic Acid in Urine by Liquid Chromatography–Electrospray Tandem Mass Spectrometry

Mohamed S. Rashed1a, Minnie Jacob1, Mohamed Al-Amoudi1, Zuhair Rahbeeni2, Moeen A.D. Al-Sayed2, Lujane Al-Ahaidib1, Amal A.A. Saadallah1 and Sharon Legaspi1

Departments of
1 Genetics and
2 Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia

aaddress correspondence to this author at: Metabolic Screening Laboratory, King Faisal Specialist Hospital and Research Centre, PO Box 3354, Riyadh 11211, Saudi Arabia; fax 966-1-442-4546, e-mail rashed@kfshrc.edu.sa

The first 300 words of the full text of this article appear below.

Orotic acid (ORA) is an important biochemical marker for uridine monophosphate synthase deficiency, an autosomal recessive disease characterized by macrocytic hypochromic megaloblastic anemia, growth retardation, orotic aciduria, and crystalluria (1). In addition, patients with urea cycle diseases excrete increased amounts of urinary ORA (2). Thus, ORA aciduria is observed in patients with ornithine carbamoylasetransferase deficiency (OCTD), an X-linked disorder, and could reveal heterozygosity after a protein load, and in citrullinemia, argininosuccinic aciduria, and argininemia (2)(3).

Currently there are two widely accepted approaches to the determination of urinary ORA, stable-isotope-dilution gas chromatography–mass spectrometry (GC/MS), and ion-exchange HPLC methods with ultraviolet detection, each of which has difficulties and limitations (4)(5)(6)(7). Ito et al.(8) recently described a liquid chromatography–electrospray tandem mass spectrometry (LC-ESI-MS/MS) method for a large number of urinary metabolites, including ORA. In the present work we describe a more specific, high-throughput, sensitive stable-isotope-dilution LC-ESI-MS/MS method for the determination of urinary ORA.

ORA was purchased from Sigma, and [1,3-15N2]orotic acid used as internal standard (IS) was obtained from Cambridge Isotope Laboratories. Acetonitrile and glacial acetic used for HPLC were purchased from Fisher Scientific. Syringe-driven membrane filter units were of LCR type (0.45 µm pore size) obtained from Millipore. Glass autosampler vials (2-mL capacity) and 300-µL vial inserts were purchased from Agilent. Urine samples were from pediatric patients investigated for metabolic diseases. Adult urine samples were from healthy laboratory personnel. All urine samples were stored at -20 °C until analysis.

MS/MS analysis was carried out on a Micromass QuattroLC triple quadrupole mass spectrometer interfaced with a Z-spray ESI source and equipped with a Jasco HPLC pump Model PU-980 and a Jasco Model AS-950 autosampler. The ESI source was operated in the negative-ion mode . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. B.P. van Kuilenburg, H. van Lenthe, M. Loffler, and A. H. van Gennip
Analysis of Pyrimidine Synthesis "de Novo" Intermediates in Urine and Dried Urine Filter- Paper Strips with HPLC-Electrospray Tandem Mass Spectrometry
Clin. Chem., November 1, 2004; 50(11): 2117 - 2124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.